17 results
8-K
EX-99.3
ELTX
Elicio Therapeutics Inc.
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
) compromised of equal membership from each of Elicio and Regeneron will meet quarterly to oversee and coordinate the study.
Each party will provide … . The IRB must continue to oversee the clinical trial while it is being conducted. If a product candidate is being investigated for multiple intended
DEF 14A
ELTX
Elicio Therapeutics Inc.
27 Apr 22
Definitive proxy
4:04pm
with Section 3(a)(58)(A) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), to oversee Angion’s corporate accounting
10-Q
t50nszx0kktj1an1 1e
17 May 21
Quarterly report
6:03am
10-K
w4gjv6gct7fz2eztg
30 Mar 21
Annual report
5:00pm
424B4
o51aelcvhjn
5 Feb 21
Prospectus supplement with pricing info
5:12pm
DRS/A
n8vjgwut8vr
15 Dec 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.10
6djcz1rt
15 Dec 20
Draft registration statement (amended)
12:00am
DRS/A
xekg3d4hp53rpav
13 May 20
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next